Count | |
| 2 | |
| 1 | |
| 1 | |
| 1 | |
2-Chloroadenosine/*analogs & derivatives/pharmacokinetics/*toxicity | 1 |
2-Chloroadenosine/adverse effects/analogs & derivatives/therapeutic use | 1 |
| 4 | |
| 3 | |
| 5 | |
| 3 | |
| 7 | |
| 3 | |
| 1 | |
| 4 | |
| 7 | |
| 14 | |
| 4 | |
| 1 | |
| 4 | |
| 6 | |
| 2 | |
| 3 | |
| 1 | |
| 10 | |
| 1 | |
| 1 | |
| 1 | |
| 1 | |
| 17 | |
| 1 | |
| 11 | |
| 28 | |
| 1 | |
| 4 | |
| 2 | |
| 15 | |
| 1 | |
| 1 | |
| 1 | |
| 9 | |
| 10 | |
| 3 | |
| 5 | |
| 5 | |
| 6 | |
| 22 | |
| 1 | |
| 7 | |
| 2 | |
| 1 | |
| 28 | |
| 1 | |
| 4 | |
| 19 | |
| 2 | |
| 2 | |
| 7 | |
| 8 | |
| 8 | |
| 2 | |
| 16 | |
| 10 | |
| 1 | |
| 4 | |
| 6 | |
| 10 | |
| 6 | |
| 2 | |
| 1 | |
| 1 | |
| 6 | |
| 6 | |
| 1 | |
| 9 | |
| 22 | |
| 24 | |
| 3 | |
| 1 | |
| 1 | |
| 2 | |
| 1 | |
| 3 | |
| 3 | |
| 2 | |
| 1 | |
| 6 | |
| 1 | |
| 6 | |
| 9 | |
| 33 | |
| 4 | |
| 1 | |
| 10 | |
| 2 | |
| 9 | |
| 1 | |
| 1 | |
| 1 | |
| 2 | |
| 15 | |